We are live on ! Find out more
IDNA icon

iShares Genomics Immunology and Healthcare ETF
IDNA

58 hedge funds and large institutions have $55M invested in iShares Genomics Immunology and Healthcare ETF in 2025 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

21% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 14

14% more funds holding

Funds holding: 51 → 58 (+7)

12% more capital invested

Capital invested by funds: $49.1M → $55M (+$5.9M)

0.35% more ownership

Funds ownership: 41.36% → 41.71% (+0.35%)

Holders
58
Holders Change
+7
Holders Change %
+13.73%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
17
Reduced
14
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$1.51M
2
Ameriprise
Ameriprise
Minnesota
+$741K
3
LPL Financial
LPL Financial
California
+$352K
4
FTUS
Flow Traders U.S.
New York
+$352K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$326K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$1.9M
2
USCWA
U.S. Capital Wealth Advisors
Texas
-$553K
3
Citadel Advisors
Citadel Advisors
Florida
-$328K
4
WBG
Wharton Business Group
Pennsylvania
-$325K
5
SWGC
Summit Wealth Group (Colorado)
Colorado
-$292K
Name Holding Trade Value Shares
Change 		Change in
Stake
Envestnet Asset Management
26
Envestnet Asset Management
Illinois
$246K +$242K +9,398 New
MML Investors Services
27
MML Investors Services
Massachusetts
$231K +$227K +8,827 New
FHC
28
First Heartland Consultants
Missouri
$228K +$1.13K +44 +0.5%
Osaic Holdings
29
Osaic Holdings
Arizona
$228K +$23.5K +914 +12%
AIA
30
Ally Invest Advisors
North Carolina
$218K -$32K -1,244 -13%
OIA
31
OneDigital Investment Advisors
Kansas
$205K +$202K +7,835 New
FFA
32
Founders Financial Alliance
North Carolina
$89.4K +$309 +12 +0.4%
KAS
33
Kestra Advisory Services
Texas
$77.6K +$76.2K +2,963 New
Rockefeller Capital Management
34
Rockefeller Capital Management
New York
$60.8K +$6.46K +251 +12%
T
35
Tidemark
California
$36.6K +$51 +2 +0.1%
TCM
36
Triumph Capital Management
Colorado
$33.1K +$32.5K +1,263 New
SS
37
Sunbelt Securities
Texas
$26.2K – – –
VR
38
Vision Retirement
New Jersey
$19.6K +$19.3K +750 New
Northwestern Mutual Wealth Management
39
Northwestern Mutual Wealth Management
Wisconsin
$13.6K +$13.4K +520 New
PCFFS
40
Pacific Center for Financial Services
California
$13K – – –
Qube Research & Technologies (QRT)
41
Qube Research & Technologies (QRT)
United Kingdom
$8.64K +$8.49K +330 New
FDCDDQ
42
Federation des caisses Desjardins du Quebec
Quebec, Canada
$7.86K – – –
Comerica Bank
43
Comerica Bank
Texas
$7.7K +$7.56K +294 New
IA
44
IFP Advisors
Florida
$7.62K – – –
MMCM
45
Murphy & Mullick Capital Management
New York
$7.2K – – –
FFA
46
Farther Finance Advisors
California
$6.73K +$1.98K +77 +43%
AIC
47
Archer Investment Corporation
Indiana
$6.5K – – –
CWMS
48
CFG Wealth Management Services
Indiana
$5.24K +$5.14K +200 New
PA
49
Parallel Advisors
California
$5.24K +$5.14K +200 New
GWM
50
Geneos Wealth Management
Colorado
$4.33K +$26 +1 +0.6%
1
2
3

IDNA Hedge Fund Activity: Q4 2025 in Review

58 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q4 2025, worth a combined $55M — up 12% from $49.1M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new IDNA positions and 8 closed out — a net gain of 7 holders — while 17 added to existing stakes and 14 trimmed.

The largest buyer was Bank of America, adding an estimated $1.51M. The largest seller was UBS Group, cutting an estimated $1.9M.

  • 58 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q4 2025, up from 51 in Q3 2025.
  • Funds reported $55M of iShares Genomics Immunology and Healthcare ETF stock for Q4 2025, up 12% quarter-over-quarter.
  • 15 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q4 2025 and 8 closed out, a net change of +7 holders.
  • The largest iShares Genomics Immunology and Healthcare ETF buyer in Q4 2025 was Bank of America, an estimated $1.51M added.
  • The largest iShares Genomics Immunology and Healthcare ETF seller in Q4 2025 was UBS Group, an estimated $1.9M sold.

Based on aggregated 13F filings for Q4 2025.